Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 407 | 163 | 174 | 333 | 153 |
| Gross Profit | 407 | 163 | 174 | 333 | 153 |
| Operating Expenses | 28,103 | 36,559 | 23,431 | 20,673 | 20,977 |
| Operating Income | -27,696 | -36,396 | -23,257 | -20,340 | -20,824 |
| Other Income | 912 | 392 | 207 | 192 | 145 |
| Pre-tax Income | -26,784 | -36,004 | -23,050 | -20,148 | -20,679 |
| Income Tax | N/A | N/A | N/A | N/A | -227 |
| Net Income Continuous | -26,784 | -36,004 | -23,050 | -20,148 | -20,452 |
| Net Income | $-26,784 | $-36,004 | $-23,050 | $-20,148 | $-20,452 |
| EPS Basic Total Ops | -0.57 | -0.77 | -0.49 | -0.43 | -0.45 |
| EPS Basic Continuous Ops | -0.57 | -0.77 | -0.49 | -0.44 | -0.45 |
| EPS Diluted Total Ops | -0.57 | -0.77 | -0.49 | -0.43 | -0.45 |
| EPS Diluted Continuous Ops | -0.57 | -0.77 | -0.49 | -0.44 | -0.45 |
| EBITDA(a) | $-26,967 | $-35,119 | $-21,674 | $-15,865 | $-23,306 |